Dave is a close friend of patient Chuck Wakefield and an avid cyclist. He also has close connections with other multiple myeloma patients and lost his father to Leukemia. His ride is dedicated to Chuck and all those facing a blood cancer. He knows that progress takes people like him willing to train and ride to bring about the awareness and funds needed to find a cure.
At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.About Janssen Oncology
Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.Learn More